Treatment can no longer be one dimensional.
Across the continent, governments and hospitals are purchasing robotics systems from abroad as well as developing the technologies themselves.
All of the issues that ECRI calls out on its list are preventable, so device manufacturers and healthcare providers should take serious note.
Part II of this series proposes that structured expert judgment, when integrated into the current HFE/UE paradigm, can help overcome some of the current limitations of HFE/UE.
This complimentary event will give attendees insights on the market landscape and potential areas of opportunity.
Medical device companies will be driven to evolve their business models to a more patient/consumer-centric approach.
The transition to digital in healthcare is happening at a fast pace.
It is the pot of gold at the end of the medical rainbow—the promise that, by harnessing data, researchers can tailor drugs, devices, and treatments to the genetic configuration, lifestyle, and environment of individual patients.
As medical devices using software and wireless communication become more ubiquitous, hackers are becoming more advanced in their methods.
The revolution in data and technology should be pushing companies to focus on safeguarding intellectual property.